Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Veterinary antibiotic sales at record low, report shows
"Through combined efforts across Government and industry, we continue to make progress in reducing the use of antibiotics in animals, which is vital for public and animal health" -- Abi Seager, VMD CEO. 

Figures show a 57 per cent decline over the past decade.

A new government report shows sales of veterinary antibiotics in the UK are at a record low. 

Figures from the Veterinary Antimicrobial Resistance and Sales Surveillance (VARRS) Report, published by the Veterinary Medicines Directorate (VMD), show a 57 per cent decrease in UK antibiotic sales for livestock. 

This means the UK remains one of the lowest prescribers of veterinary antibiotics in Europe, and that it has achieved some of the biggest reductions in AMR in the past year.

Significantly, data published earlier this year from the Animal Plant and Health Agency confirms a strong link between reduced antibiotic use and reduced AMR in animals, supported by a decade of surveillance data. 

The report shows clear declines in resistance, including healthy animals at slaughter, and sustained reductions in antibiotic sales for use in cats and dogs — reflecting efforts to improve stewardship across the sector. 

Usage within the trout and salmon sectors is also at its lowest to date. 

Conversely, the use of antibiotics in the pig and game bird sectors has increased, highlighting a need for renewed action across the farming sector. 

The report notes an unexpected increase increase in E. coli in chickens bred and raised for meat production, despite reduced antibiotics use. However, there has been no increase in multi-drug resistance or resistance to the highest-priority antibiotics.

VMD CEO Abi Seager said: “This year’s report shows that through the ongoing hard work of vets and farmers across the UK we can make real progress in the fight against AMR.
 
“Overall use of antibiotics in livestock remains at its lowest level and importantly use of the most critical antibiotics for human health remains extremely low. This is reflected in results from our AMR surveillance programmes, which show an encouraging picture of AMR reducing in animals.” 

Minister for biosecurity, borders and animal welfare, Baroness Hayman, added: “Through combined efforts across Government and industry we continue to make progress in reducing the use of antibiotic in animals, which is vital for public and animal health.”
 
“We remain committed to leading the global fight against antimicrobial resistance and to maintaining our place as one of the lowest users of veterinary antibiotics across Europe, so future generations can benefit.”

Image (C) Aleksander Malivuk/Shutterstock.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.